FWP 1 a18-6475_3fwp.htm FWP

 

 

Filed Pursuant to Rule 433

Registration Statement No. 333-223095

Issuer Free Writing Prospectus, dated February 22, 2018

 

Boston Scientific Corporation

 

$1,000,000,000

Senior Notes Offering

 

Terms and Conditions — 10-Year Fixed Rate Notes

 

Issuer

 

Boston Scientific Corporation

 

 

 

Note Type

 

Senior Notes

 

 

 

Form of Offering

 

SEC Registered

 

 

 

Ratings(1)

 

Baa2/BBB-/BBB (stable/stable/stable)

 

 

 

Principal Amount

 

$1,000,000,000

 

 

 

Trade Date

 

February 22, 2018

 

 

 

Settlement Date (T+2)

 

February 26, 2018

 

 

 

Maturity Date

 

March 1, 2028

 

 

 

Coupon

 

4.000% per annum

 

 

 

Yield to Maturity

 

4.021% per annum

 

 

 

Price to Public

 

99.828%

 

 

 

Spread to Benchmark Treasury

 

Plus 110 basis points

 

 

 

Benchmark Treasury

 

2.750% UST due February 15, 2028

 

 

 

Benchmark Treasury Yield

 

2.921%

 

 

 

Benchmark Treasury Price

 

98-17

 

 

 

Interest Payment Dates

 

Semi-annually on March 1 and September 1

 

 

 

First Interest Payment Date

 

September 1, 2018

 

 

 

Make-whole Call

 

Plus 20 basis points

 

 

 

Day Count Basis

 

30/360

 

 

 

Minimum Denominations

 

$2,000 and integral multiples of $1,000 in excess of such amount

 

 

 

CUSIP / ISIN

 

101137AS6 / US101137AS67

 

 

 

Joint Bookrunners

 

Barclays Capital Inc.

Citigroup Global Markets Inc.

Merrill Lynch, Pierce, Fenner & Smith

Incorporated

Deutsche Bank Securities Inc.

J.P. Morgan Securities LLC

Wells Fargo Securities, LLC

 

 

 

Co-Managers

 

BNP Paribas Securities Corp.

 


 

 

 

DNB Markets, Inc.

MUFG Securities Americas Inc.

RBC Capital Markets, LLC

Scotia Capital (USA) Inc.

SMBC Nikko Securities America, Inc.

Standard Chartered Bank

TD Securities (USA) LLC

U.S. Bancorp Investments, Inc.

 

Note:

 

(1)                     A securities rating is not a recommendation to buy, sell or hold securities and may be subject to revision or withdrawal at any time.

 

The Issuer has filed a registration statement (including a preliminary prospectus supplement and accompanying prospectus) with the U.S. Securities and Exchange Commission (the “SEC”) for the offering to which this communication relates.  Before you invest, you should read the preliminary prospectus supplement and accompanying prospectus and other documents the Issuer has filed with the SEC for more complete information about the Issuer and this offering.  You may get these documents for free by visiting EDGAR on the SEC Web site at www.sec.gov.  Alternatively, the Issuer, any underwriter or any dealer participating in the offering will arrange to send you the preliminary prospectus supplement and accompanying prospectus if you request it by calling Barclays Capital Inc. toll-free at (888) 603-5847, Citigroup Global Markets Inc. toll-free at (800) 831-9146 or Merrill Lynch, Pierce, Fenner & Smith Incorporated toll-free at (800) 294-1322.

 

Any disclaimers or other notices that may appear below are not applicable to this communication and should be disregarded.  Such disclaimers or other notices were automatically generated as a result of this communication being sent via Bloomberg or another email system.

 

2